Chronisch Hartfalen, Chronic Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients are eligible when they; 1. Have symptomatic, systolic HF (NYHA II-III); 2. Are visiting the Heart Failure clinic of one of the participating centres; 3. Have HF with evidence for structural underlying ventricular dysfunction (LVEF<40%); 4. Are up titrated to optimal pharmacological treatment (notably use of adequate dosages of ACE-inhibitors/ARBs and beta blockers); 5. Are in a stable condition; no hospital admissions in the previous month, no visits at the emergency unit for decompensation in the previous month, no unplanned medication changes in the previous month; 6. Have received information and education on heart failure and the required life style changes following a pre-specified protocol; 7. Are aged above 18 years.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the study when; 1. Patient management by a cardiologist planned for diagnostics or treatment is needed; 2. The patient has restrictions that render patients to fill in data collection materials (non-mastering of the Dutch language); 3. The patient has a life expectancy shorter than 6 months; 4. The patient has a current psychiatric disorder as documented in the medical record.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Guideline Adherence with Pharmacologicial treatment of Heart Failure; 2. Patient compliance with medication. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Guideline Adherence Optimal Dose; 2. Number of hospital readmissions; 3. Mortality; 4. Patient compliance with lifestyle recommendations on diet, fluid and weighing; 5. Quality of Life; 6. Guideline Adherence devices | — |
Contacts
Postbus 30001